MRKR · Marker Therapeutics, Inc. · Earnings Calls, Transcripts & Webcasts
$1.09
-0.23 (-17.42%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2021 earnings call transcript
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 16, 2026
Market Cap
$18.17M
Shares
16.67M
Volume · Nov 20
1.97M
Avg daily vol (3M)
703.97K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Marker Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Marker Therapeutics, Inc. (MRKR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY21 · Q3
2021-11-10
Marker Therapeutics, Inc. (MRKR) Q3 2021 Earnings Call
Net income
−$12.43M
Diluted EPS
$-1.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
Marker Therapeutics, Inc. (MRKR) Q1 2021 Earnings Call Transcript
Net income
−$8.78M
Diluted EPS
$-1.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-09
Marker Therapeutics, Inc. (MRKR) Q3 2020 Earnings Call Transcript
Revenue
$0
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Marker Therapeutics, Inc. (MRKR) Q1 2020 Earnings Call Transcript
Net income
−$6.49M
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 webcasts
Key facts
CIK
1094038
CUSIP
57055L206
13F (30d)
51 filings
34 filers
Visit website
Investor relations